Sinopharm CICC Medical Industry Venture Fund I Overview
Sinopharm CICC Medical Industry Venture Fund I General Information
Description
Sinopharm CICC Medical Industry Venture Fund I is a 2018 vintage venture capital fund managed by Sinopharm CICC. The fund is located in Shanghai and will invest in China. The fund targets healthcare and prefers health tech, life sciences, industrial, pharmaceutical retail, medical equipment, medical services and bio-innovative drugs.
Contact Information
Fund Manager's Location
- Unit 03, 9th Floor, Baowu Building 2
- 1859 Shibo Avenue, Pudong New Area
- Shanghai
- China
Sinopharm CICC Medical Industry Venture Fund I Investments (4)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Hinova Pharmaceuticals | 31-Aug-2020 | Drug Discovery | Clinical Trials - Phase 3 | |||
| MicuRx Pharmaceuticals | 05-Aug-2020 | Pharmaceuticals | Clinical Trials - Phase 3 | |||
| Suzhou Ribo Life Science | 03-Apr-2020 | Later Stage VC (Series C2) | Biotechnology | Generating Revenue | ||
| Landing Med | 01-Jan-2020 | Later Stage VC (Series C) | Diagnostic Equipment | Generating Revenue |
Sinopharm CICC Medical Industry Venture Fund I Investment Strategy
Investments by Industry
Investments by Deal Type
Sinopharm CICC Medical Industry Venture Fund I Limited Partners (1)
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| China National Medicines Corporation | Current | 14-Jun-2018 | Original |
Sinopharm CICC Medical Industry Venture Fund I Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
Sinopharm CICC Medical Industry Venture Fund I Benchmark (22)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| Unicorn Partners Fund II | 31-Dec-2019 | ||||
| Gaorong USD Fund IV | |||||
| Long Hill Capital Venture Partners II | 31-Dec-2023 | ||||
| Sinovation Fund IV | 30-Jun-2024 | ||||
| Shunwei China Internet Fund IV | |||||
| Qiming Venture Partners VI | |||||
| Shunwei China Internet Opportunity Fund III | |||||
| Genesis Capital II | 31-Dec-2022 | ||||
| Matrix Partners India III | |||||
| Matrix Partners China V |
Sinopharm CICC Medical Industry Venture Fund I FAQs
-
What is Sinopharm CICC Medical Industry Venture Fund I?
Sinopharm CICC Medical Industry Venture Fund I is a 2018 vintage venture capital fund managed by Sinopharm CICC.
-
Who manages Sinopharm CICC Medical Industry Venture Fund I?
Sinopharm CICC Medical Industry Venture Fund I is managed by Sinopharm CICC.
-
Where is Sinopharm CICC Medical Industry Venture Fund I domiciled?
Sinopharm CICC Medical Industry Venture Fund I is domiciled in China.
-
What is Sinopharm CICC Medical Industry Venture Fund I's size?
Sinopharm CICC Medical Industry Venture Fund I has a size of $469M.
-
What type of fund is Sinopharm CICC Medical Industry Venture Fund I?
The fund type of Sinopharm CICC Medical Industry Venture Fund I is Venture.
-
What is the status of Sinopharm CICC Medical Industry Venture Fund I?
Sinopharm CICC Medical Industry Venture Fund I is closed.
-
What has Sinopharm CICC Medical Industry Venture Fund I invested in?
Sinopharm CICC Medical Industry Venture Fund I has made numerous investments in companies like Hinova Pharmaceuticals, MicuRx Pharmaceuticals, and Suzhou Ribo Life Science within the Drug Discovery, Pharmaceuticals, and Biotechnology industries.
-
What has Sinopharm CICC Medical Industry Venture Fund I invested in recently?
Sinopharm CICC Medical Industry Venture Fund I's latest investment was on 31-Aug-2020 in Hinova Pharmaceuticals, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
